M. Hamilton

1.6k total citations
12 papers, 38 citations indexed

About

M. Hamilton is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, M. Hamilton has authored 12 papers receiving a total of 38 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Internal Medicine and 3 papers in Economics and Econometrics. Recurrent topics in M. Hamilton's work include Atrial Fibrillation Management and Outcomes (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Statistical Methods in Clinical Trials (3 papers). M. Hamilton is often cited by papers focused on Atrial Fibrillation Management and Outcomes (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Statistical Methods in Clinical Trials (3 papers). M. Hamilton collaborates with scholars based in United States, United Kingdom and Belgium. M. Hamilton's co-authors include L. Vo, Xuemei Luo, Ajibade Ashaye, Ruslan Horblyuk, X Li, Steve Deitelzweig, Caroline Farmer, Alexander T. Cohen, Chantelle Browne and Tereza Lanitis and has published in prestigious journals such as European Heart Journal, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

M. Hamilton

9 papers receiving 38 citations

Peers

M. Hamilton

CCM

EPIDE

ONCOL

Angelina Camiletti Brazil

Finn Schünemann Germany

Ömer Erküner Netherlands

Ana Dimova United States

С. А. Зенин Russia

F. Martín‐Martos Spain

Tovohery Andriambelo Rajaonera Democratic Republic of the Congo

Y. J. Stevenhagen Netherlands

Sandro Aquilanti France

Nishan K Purayil Qatar

Angelina Camiletti Brazil

M. Hamilton

86 ×2.9

CCM

15 ×0.7

5 ×0.8

3 ×0.8

EPIDE

2 ×0.7

ONCOL

Citations per year, relative to M. Hamilton M. Hamilton (= 1×) peers Angelina Camiletti

Countries citing papers authored by M. Hamilton

Since Specialization

Citations

This map shows the geographic impact of M. Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hamilton more than expected).

Fields of papers citing papers by M. Hamilton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hamilton. The network helps show where M. Hamilton may publish in the future.

Co-authorship network of co-authors of M. Hamilton

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hamilton. A scholar is included among the top collaborators of M. Hamilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hamilton. M. Hamilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Hamilton, M. & Mark Fisher. (2024). Opening the Thucydides trap: a genealogy of rise-and-fall theory. International Affairs. 100(3). 1189–1206.

Goring, Sarah, et al.. (2022). POSC308 Network Meta-Analysis Under Survival Heterogeneity with Long-Term Survival: A Case Study from Adjuvant Treatment of Resected Stage III/IV Melanoma. Value in Health. 25(1). S208–S208. 1 indexed citations

Larkin, James, Everardo D. Saad, Peter G. Mohr, et al.. (2022). 816P Investigating surrogate endpoints (SE) for overall survival (OS) in first-line (1L) advanced melanoma: A pooled-analysis of immune checkpoint inhibitor (ICI) trials. Annals of Oncology. 33. S919–S920.

Leung, Lai K., Eric Chou, Murat Kurt, et al.. (2022). POSA24 Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in Previously Untreated Advanced Melanoma: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS). Value in Health. 25(1). S22–S22.

Porta, Camillo, Robert J. Motzer, Flavia Ejzykowicz, et al.. (2021). 668P Matching-adjusted indirect comparison (MAIC) of health-related quality of life (HRQoL) of nivolumab plus cabozantinib (N+C) vs pembrolizumab plus axitinib (P+A) in previously untreated advanced renal cell carcinoma (aRCC). Annals of Oncology. 32. S692–S693. 1 indexed citations

Hamilton, M.. (2019). Debating Algorithmic Fairness. Surrey Research Insight Open Access (The University of Surrey). 2 indexed citations

Watsky, Eric, Nelly A. Kuklin, M. Hamilton, & Sharon Barr. (2017). Maintenance of disease-relevant biomarker improvement in patients with Molybdenum Cofactor Deficiency (MoCD) Type A administered ALXN1101, a synthetic form of cyclic pyranopterin monophosphate. European Journal of Paediatric Neurology. 21. e124–e124. 2 indexed citations

Deitelzweig, Steve, Caroline Farmer, Xuemei Luo, et al.. (2017). Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies. Current Medical Research and Opinion. 33(9). 1583–1594. 24 indexed citations

Browne, Chantelle, Tereza Lanitis, M. Hamilton, et al.. (2016). Impact of apixaban vs low molecular weight heparin/vitamin k antagonist on hospital resource use in patients with venous thromboembolism. Journal of Medical Economics. 20(1). 98–106. 2 indexed citations

10.

Lanitis, Tereza, et al.. (2014). Cost-Effectiveness Of Apixaban Compared To Other Anticoagulants For Lifetime Treatment And Prevention Of Recurrent Venous Thromboembolism. Value in Health. 17(7). A488–A488. 4 indexed citations

11.

Pan, Xiangbin, et al.. (2013). Patient characteristics associated with the initiation of novel oral anticoagulants versus warfarin in patients with atrial fibrillation. European Heart Journal. 34(suppl 1). P543–P543. 1 indexed citations

12.

Krauze, Andra, Sagar A. Patel, Sunita Ghosh, et al.. (2010). Prognostic Factors for Survival and Recurrence in Adult Medulloblastoma. International Journal of Radiation Oncology*Biology*Physics. 78(3). S269–S269. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact